SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
基本信息
- 批准号:2684735
- 负责人:
- 金额:$ 19.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-09-15 至 1999-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The studies to be conducted under this grant fall in four major areas:
1) complete work on the total synthesis of the hypoglycemic agent Saudin
(1); test 1 and its precursors to identify the pharmacophore, and
determine if possible the mechanism by which the hypoglycemic effects are
elicited (in collaboration with Sandoz Research Institute); prepare
appropriate analogues as warranted by the preceding studies;
2) continue work directed at the application of Lewis acid catalyzed
asymmetric [2+2] cycloaddition reactions to (+)-Laurencin (2) and
Laurenyne (3) which employs a novel retro-Claisen rearrangement to create
the required oxocene ring system in enantiomerically pure form;
3) continue preliminary studies begun recently directed toward the
preparation of the novel squalene synthetase inhibitor (+)-Zaragozic Acid
C, one of a group of novel antifungal enzyme inhibitors known as the
squalestatins 1-3 and the Zaracozic Acids A-C isolated by Glaxo and Merck
groups. The approach utilizes a novel application of a net [4-3]
cycloaddition to construct the core of the novel squalene synthetase
inhibitor Zaragozic Acid C (4); and,
4) initiate synthetic studies directed toward UCT4B (6), a recently
characterized DNA gyrase inhibitor, which holds promise as both an
antibiotic and a potentially antitumor agent. UCT4B (6) is a member of a
small but growing group of biologically active diterpene derivatives which
also includes Clerocidin and Terpenticin. A novel protection scheme
employing a chiral diol acetal is envisioned to permit control over the
key asymmetric centers present in the acyclic chain and provide convenient
access to an immediate precursor of the sensitive alpha-ketoaldehyde unit.
在这项资助下进行的研究分为四个主要范畴:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT K BOECKMAN其他文献
ROBERT K BOECKMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT K BOECKMAN', 18)}}的其他基金
Development of novel bone-targeted chloroquine conjugates to prevent bone resorption.
开发新型骨靶向氯喹结合物以防止骨吸收。
- 批准号:
9355087 - 财政年份:2016
- 资助金额:
$ 19.12万 - 项目类别:
Study of osteoblast regulation in TNF-mediated bone loss
TNF介导的骨丢失中成骨细胞调节的研究
- 批准号:
8891736 - 财政年份:2013
- 资助金额:
$ 19.12万 - 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
- 批准号:
2175770 - 财政年份:1982
- 资助金额:
$ 19.12万 - 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
- 批准号:
3278043 - 财政年份:1982
- 资助金额:
$ 19.12万 - 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
- 批准号:
3278052 - 财政年份:1982
- 资助金额:
$ 19.12万 - 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
- 批准号:
6342785 - 财政年份:1982
- 资助金额:
$ 19.12万 - 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
- 批准号:
3278051 - 财政年份:1982
- 资助金额:
$ 19.12万 - 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
- 批准号:
3278053 - 财政年份:1982
- 资助金额:
$ 19.12万 - 项目类别:
相似海外基金
Biosynthesis of peptidyl nucleoside antifungal antibiotics
肽基核苷抗真菌抗生素的生物合成
- 批准号:
8944844 - 财政年份:2015
- 资助金额:
$ 19.12万 - 项目类别:
Screening for new antifungal antibiotics of microbial origin using silkworm infection model with Candida albicans
利用家蚕白色念珠菌感染模型筛选新型微生物源抗真菌抗生素
- 批准号:
25460130 - 财政年份:2013
- 资助金额:
$ 19.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synthesis and Biological Evaluation of Antifungal Antibiotics, Spirofungin A and B
抗真菌抗生素螺芬净 A 和 B 的合成及生物学评价
- 批准号:
16590026 - 财政年份:2004
- 资助金额:
$ 19.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




